Swagata Basu, Scientific Communications & Research Strategy Leader, Driving Institutional Excellence in Academic Medicine, shared on LinkedIn:
“Thank you to Dr. Anirban Maitra, Director of the Perlmutter Cancer Center at NYU Grossman School of Medicine, for speaking at today’s Tisch Cancer Center Seminar Series!
His talk, ‘Mediators of Restraint in Early Pancreatic Neoplasia,’ explored a key question: most early pancreatic lesions share the same mutations as deadly cancer, but natural biological barriers usually keep them dormant.
By understanding how these restraints work, from KRAS variants to immune responses to proteins like NKX6-2, researchers hope to develop new ways to stop pancreatic cancer before it ever starts.
Thanks also to our host, Dr. Poulikos Poulikakos, for inviting him.”
You may also be interested in:
Anirban Maitra: New Insights Into Targeted Therapy Sensitivity in Pancreatic Cancer